<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Prescription drug monitoring</title>
    <subTitle>strategies to promote treatment and deter prescription drug use : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, March 4, 2004</subTitle>
  </titleInfo>
  <titleInfo type="alternative">
    <title>Strategies to promote treatment and deter prescription drug use</title>
  </titleInfo>
  <name type="corporate">
    <namePart>United States</namePart>
    <namePart>Congress.</namePart>
    <namePart>House.</namePart>
    <namePart>Committee on Energy and Commerce.</namePart>
    <namePart>Subcommittee on Health.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">dcu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Washington</placeTerm>
    </place>
    <publisher>U.S. G.P.O.</publisher>
    <publisher>For sale by the Supt. of Docs., U.S. G.P.O.</publisher>
    <dateIssued>2004</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">microfiche</form>
    <extent>iii, 73 pages : illustrations ; 24 cm</extent>
  </physicalDescription>
  <note>"Printed for the use of the Committee on Energy and Commerce."</note>
  <note>Shipping list no.: 2004-0382-M.</note>
  <note>"Serial no. 108-73."</note>
  <note>CRDP Program record.</note>
  <note>Includes bibliographical references.</note>
  <note>Microfiche. Washington : Supt. of Docs., U.S. G.P.O., 2004. 1 microfiche : negative.</note>
  <subject>
    <geographicCode authority="marcgac">n-us---</geographicCode>
  </subject>
  <subject authority="lcsh">
    <topic>Medication abuse</topic>
    <geographic>United States</geographic>
    <topic>Prevention</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Medication abuse</topic>
    <topic>Law and legislation</topic>
    <geographic>United States</geographic>
  </subject>
  <classification authority="sudocs">Y 4.C 73/8:108-73</classification>
  <classification authority="">Y 4.C 73/8:108-73</classification>
  <relatedItem type="otherFormat" displayLabel="Online version:">
    <titleInfo>
      <title>Prescription drug monitoring</title>
    </titleInfo>
    <name>
      <namePart>United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.</namePart>
    </name>
    <identifier type="local">(OCoLC)680494127</identifier>
  </relatedItem>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Prescription drug monitoring</title>
    </titleInfo>
    <name>
      <namePart>United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.</namePart>
    </name>
    <identifier type="local">(OCoLC)55688393</identifier>
  </relatedItem>
  <identifier type="isbn">0160717140</identifier>
  <identifier type="isbn">9780160717147</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">PUCPR</recordContentSource>
    <recordCreationDate encoding="marc">040721</recordCreationDate>
    <recordChangeDate encoding="iso8601">20180706132118.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocm55983220</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
